116 related articles for article (PubMed ID: 7899266)
1. Tumour-associated antigens in maternal and fetal blood.
Hohlfeld P; Dang TT; Nahoul K; Daffos F; Forestier F
Prenat Diagn; 1994 Oct; 14(10):907-12. PubMed ID: 7899266
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of neuron-specific enolase, carbohydrate antigen 19-9 and carbohydrate antigen 125 in carcinoma of the lung.
Oktay G; Güner G; Karlikaya C; Akkoçlu A
Biochem Soc Trans; 1995 May; 23(2):211S. PubMed ID: 7672232
[No Abstract] [Full Text] [Related]
3. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
Yang J; Tang A; Ma J; Sun X; Ming L
Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
[TBL] [Abstract][Full Text] [Related]
4. Acquired renal cystic disease and tumor markers in chronic hemodialysis patients.
Polenakovic M; Sikole A; Dzikova S; Polenakovic B; Gelev S
Int J Artif Organs; 1997 Feb; 20(2):96-100. PubMed ID: 9093887
[TBL] [Abstract][Full Text] [Related]
5. Serum MCA, CA 125 and CA 19.9 determination in primary breast cancer.
Yenisey C; Güner G
Biochem Soc Trans; 1996 May; 24(2):302S. PubMed ID: 8736960
[No Abstract] [Full Text] [Related]
6. Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer.
Bergman B; Brezicka FT; Engström CP; Larsson S
Eur J Cancer; 1993; 29A(2):198-202. PubMed ID: 8380696
[TBL] [Abstract][Full Text] [Related]
7. [A preliminary study of retinoblastoma-related serum tumor markers].
Liu ZP; Zhou KY; Chen LL; Xiao ZH; Chen YZ
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Mar; 19(3):318-321. PubMed ID: 28302204
[TBL] [Abstract][Full Text] [Related]
8. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory.
Hui L; Rixv L; Xiuying Z
Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289
[TBL] [Abstract][Full Text] [Related]
9. Tumor markers in patients with chronic renal failure.
Filella X; Cases A; Molina R; Jo J; Bedini JL; Revert L; Ballesta AM
Int J Biol Markers; 1990; 5(2):85-8. PubMed ID: 1704405
[TBL] [Abstract][Full Text] [Related]
10. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
[TBL] [Abstract][Full Text] [Related]
11. Biological variation of serum neuron-specific enolase and carbohydrate antigen 724 tumor markers.
Wang S; Zhao M; Mu R; Zhang X; Yun K; Shang H
J Clin Lab Anal; 2018 May; 32(4):e22327. PubMed ID: 28926140
[TBL] [Abstract][Full Text] [Related]
12. Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
Nutini S; Cappelli G; Benucci A; Catalani C; Nozzoli F
Int J Biol Markers; 1990; 5(4):198-202. PubMed ID: 1965544
[TBL] [Abstract][Full Text] [Related]
13. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
Ma S; Shen L; Qian N; Chen K
Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers in chronic renal failure and hemodialysis patients.
Cases A; Filella X; Molina R; Ballesta AM; Lopez-Pedret J; Revert L
Nephron; 1991; 57(2):183-6. PubMed ID: 2020345
[TBL] [Abstract][Full Text] [Related]
15. Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours.
Fizazi K; Farhat F; Theodore C; Rixe O; Le Cesne A; Comoy E; Le Chevalier T
Br J Cancer; 1997; 75(1):76-8. PubMed ID: 9000601
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies directed to human lung cancer].
Kannagi R; Miyake M; Itai S; Naito M; Hashimoto K
Rinsho Kyobu Geka; 1989 Feb; 9(1):19-28. PubMed ID: 9301894
[TBL] [Abstract][Full Text] [Related]
17. Serum tumor marker immunoassays in gynecologic oncology: establishment of reference values.
Bon GG; Kenemans P; Verstraeten R; van Kamp GJ; Hilgers J
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):107-14. PubMed ID: 8571992
[TBL] [Abstract][Full Text] [Related]
18. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3.
Miserez AR; Günes I; Müller-Brand J; Walther E; Fridrich R; Mäcke H
Eur J Cancer; 1991; 27(2):126-31. PubMed ID: 1827273
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]